Germany
· Delayed Price · Currency is EUR Pentixapharm Holding AG Statistics
Total Valuation
FRA:PTP has a market cap or net worth of EUR 53.41 million. The enterprise value is 36.02 million.
| Market Cap | 53.41M |
| Enterprise Value | 36.02M |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 24.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 15.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 389.84 |
| PB Ratio | 1.18 |
| P/TBV Ratio | 5.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.14 |
| EV / Sales | 262.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.54 |
Financial Position
The company has a current ratio of 3.14
| Current Ratio | 3.14 |
| Quick Ratio | 2.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -201.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -21.74% |
| Revenue Per Employee | 1,957 |
| Profits Per Employee | -240,800 |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.68 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 27.81 |
| Average Volume (20 Days) | 56,049 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:PTP had revenue of EUR 137,000 and -16.86 million in losses. Loss per share was -0.68.
| Revenue | 137,000 |
| Gross Profit | -4.80M |
| Operating Income | -10.70M |
| Pretax Income | -20.66M |
| Net Income | -16.86M |
| EBITDA | -9.73M |
| EBIT | -10.70M |
| Loss Per Share | -0.68 |
Balance Sheet
The company has 17.39 million in cash and n/a in debt, giving a net cash position of 17.39 million.
| Cash & Cash Equivalents | 17.39M |
| Total Debt | n/a |
| Net Cash | 17.39M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 45.40M |
| Book Value Per Share | 1.83 |
| Working Capital | 13.47M |
Cash Flow
In the last 12 months, operating cash flow was -9.57 million and capital expenditures -606,000, giving a free cash flow of -10.17 million.
| Operating Cash Flow | -9.57M |
| Capital Expenditures | -606,000 |
| Free Cash Flow | -10.17M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -7,811.68% |
| Pretax Margin | -15,081.02% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:PTP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -31.56% |
| FCF Yield | -19.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:PTP has an Altman Z-Score of 4.15 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.15 |
| Piotroski F-Score | 1 |